Patrick A. Akkari

University Name

Australia

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Neurology

50%

Biostatistics

40%

Neurodegenerative Disease

60%

Medical Science

50%

Amyotrophic Lateral Sclerosis

30%

Gwas

30%

Targeted Therapy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles13

Nanopore sequencing as a novel method of characterising anorexia nervosa risk loci

Article Link

Year:

2024

Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral Sclerosis

Article Link

Year:

2024

Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review

Article Link

Year:

2023

Targeted Molecular Therapeutics for Parkinson's Disease: A Role for Antisense Oligonucleotides?

Article Link

Year:

2022

Short structural variants as informative genetic markers for ALS disease risk and progression

Article Link

Year:

2022

Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onset

Article Link

Year:

2022

Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?

Article Link

Year:

2022

Bridging the gap: Short structural variants in the genetics of anorexia nervosa

Article Link

Year:

2022

Single Stranded Fully Modified-Phosphorothioate Oligonucleotides can Induce Structured Nuclear Inclusions, Alter Nuclear Protein Localization and Disturb the Transcriptome In Vitro

Article Link

Year:

2022

p62 overexpression induces TDP-43 cytoplasmic mislocalisation, aggregation and cleavage and neuronal death

Article Link

Year:

2021

TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease

Article Link

Year:

2021

Novel STMN2 Variant Linked to Amyotrophic Lateral Sclerosis Risk and Clinical Phenotype.

Article Link

Year:

2021

New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis

Article Link

Year:

2021

Collaborators18

Megan Banks

University of Western Australia

AUSTRALIA

Khan Collins

University in Western Australia

AUSTRALIA

Sean Hood

University of Western Australia

AUSTRALIA

Anastazja Gorecki

University of Western Australia

AUSTRALIA

Sue Fletcher

Murdoch University

AUSTRALIA

Dunhui Li

University of Western Australia

AUSTRALIA

Sarah Lyn Rea

Lab Head: Functional Genomics Group; Senior Research Fellow

Perron Institute for Neurological and Translational Science

AUSTRALIA

Bradley Roberts

Perron Institute for Neurological and Translational Science

AUSTRALIA

Ryan S. Anderton

The University of Notre Dame Australia

AUSTRALIA

Flora Cheng

Macquarie University

AUSTRALIA

Jennifer Rodger

University of Western Australia

AUSTRALIA

Stuart Hodgetts

University in Western Australia

AUSTRALIA

Leon Larcher

Murdoch University

AUSTRALIA

Bernadette Majda

Senior Lecturer

Curtin University

AUSTRALIA

Jennifer Jordan

Associate Professor

University of Otago Christchurch

NEW ZEALAND

Susanne Stanley

University of Western Australia

AUSTRALIA

Madison Hoes

University in Western Australia

AUSTRALIA

Justin Yerbury

University of Wollongong

AUSTRALIA

How do I reach out?

Meet Kite AI